An upregulated level of IL-6 in the TME is strongly associated with cancer cell proliferation, epithelial to mesenchymal transition, chemoresistance, invasion, metastasis survival of tumor cells, and angiogenesis through fueling STAT3 MAPK and Akt signaling [174]. The gene discussed is IL6; the disease is neoplasm.